We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
+11.47%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$44.9B
AUM Growth
+$1.51B
(+3.5%)
Cap. Flow
-$3.93B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
9.25%
Holding
1,161
New
143
Increased
326
Reduced
483
Closed
121
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$241M |
| 2 |
PVH
PVH
|
+$206M |
| 3 |
American Airlines Group
AAL
|
+$132M |
| 4 |
STJ
St Jude Medical
STJ
|
+$127M |
| 5 |
XEC
CIMAREX ENERGY CO
XEC
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Labcorp
LH
|
+$163M |
| 2 |
Herc Holdings
HRI
|
+$160M |
| 3 |
NCR Voyix
VYX
|
+$155M |
| 4 |
Aptiv
APTV
|
+$147M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.3% |
| 2 | Industrials | 13.62% |
| 3 | Healthcare | 11.97% |
| 4 | Energy | 8.91% |
| 5 | Consumer Discretionary | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KERX
601
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $10.9M | 0.02% |
842,468
-51,302
| -6% | -$613K |
|
602
Chegg
CHGG
$121M
| $10.9M | 0.02% |
+1,277,571
| New | +$10.9M |
|
603
Vodafone
VOD
$37.7B
| $10.8M | 0.02% |
+270,273
| New | +$10.2M |
|
604
Visa
V
$697B
| $10.8M | 0.02% |
193,860
+120,508
| +164% | +$6.08M |
|
|
MDVN
605
DELISTED
MEDIVATION, INC.
MDVN
| $10.8M | 0.02% |
338,052
-751,840
| -69% | -$22.7M |
|
606
Dollar General
DG
$27.8B
| $10.7M | 0.02% |
178,001
-1,157
| -0.6% | -$68K |
|
607
SBA Communications
SBAC
$18.6B
| $10.6M | 0.02% |
117,708
+56,606
| +93% | +$4.86M |
|
608
ASML
ASML
$608B
| $10.5M | 0.02% |
112,059
+86,559
| +339% | +$8.03M |
|
609
Sanofi
SNY
$109B
| $10.5M | 0.02% |
195,728
+99,284
| +103% | +$5.12M |
|
610
ServiceNow
NOW
$114B
| $10.5M | 0.02% |
935,205
+8,710
| +0.9% | +$92K |
|
|
CERN
611
DELISTED
Cerner Corp
CERN
| $10.4M | 0.02% |
186,394
+57,675
| +45% | +$3.23M |
|
|
SYT
612
DELISTED
Syngenta Ag
SYT
| $10.3M | 0.02% |
129,296
-1,962
| -1% | -$155K |
|
613
TSMC
TSM
$2.03T
| $10.2M | 0.02% |
584,963
-33,056
| -5% | -$587K |
|
614
Zions Bancorporation
ZION
$10.1B
| $10.2M | 0.02% |
340,535
-124,161
| -27% | -$3.57M |
|
615
Ralph Lauren
RL
$22.5B
| $10.2M | 0.02% |
57,728
+8,061
| +16% | +$1.37M |
|
|
CSOD
616
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $10.1M | 0.02% |
189,421
-650,666
| -77% | -$32.3M |
|
617
TripAdvisor
TRIP
$1.74B
| $10.1M | 0.02% |
+121,750
| New | +$9.96M |
|
|
BDBD
618
DELISTED
BOULDER BRANDS INC
BDBD
| $10.1M | 0.02% |
634,354
-177,739
| -22% | -$2.76M |
|
619
Euronet Worldwide
EEFT
$3.15B
| $10M | 0.02% |
+209,449
| New | +$9.41M |
|
|
KSU
620
DELISTED
Kansas City Southern
KSU
| $10M | 0.02% |
80,726
+17,140
| +27% | +$2.05M |
|
621
Jabil
JBL
$31.7B
| $9.93M | 0.02% |
569,100
+242,183
| +74% | +$4.91M |
|
|
RENT
622
DELISTED
RENTRAK CORP
RENT
| $9.88M | 0.02% |
260,616
+63,631
| +32% | +$2.33M |
|
|
KG
623
Kestrel Group
KG
$68M
| $9.87M | 0.02% |
45,142
-4,558
| -9% | -$1.07M |
|
|
ARUN
624
DELISTED
ARUBA NETWORKS, INC.
ARUN
| $9.85M | 0.02% |
550,000
| – | – |
|
|
PSIX
625
Power Solutions International
PSIX
$643M
| $9.83M | 0.02% |
130,951
-55,103
| -30% | -$3.61M |
|
Similar funds
Lord, Abbett & Co's Q4 2013 Portfolio in Review
As of Q4 2013, Lord, Abbett & Co held 1,161 positions worth $44.9B, up 3.5% from $43.4B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Lord, Abbett & Co withdrew a net $3.93B in Q4 2013, closing 121 positions and reducing 483 holdings. Its most notable exit was Labcorp, an estimated $163M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Lord, Abbett & Co opened a new position in American Airlines Group worth $129M.
- Lord, Abbett & Co's largest Q4 2013 buy was American Airlines Group: 5,122,124 shares worth $129M.
- Lord, Abbett & Co added most to Gilead Sciences in Q4 2013, an estimated $241M increase.
- Lord, Abbett & Co's biggest Q4 2013 reduction was Herc Holdings, cutting an estimated $160M.
- Lord, Abbett & Co fully exited Labcorp in Q4 2013, selling an estimated $163M.
- Lord, Abbett & Co's ten largest holdings make up 9.3% of its $44.9B portfolio in Q4 2013.
- Lord, Abbett & Co opened 143 new positions and closed 121 in Q4 2013.
- Lord, Abbett & Co's portfolio value rose 3.5% quarter-over-quarter to $44.9B.
Based on Lord, Abbett & Co's 13F filing for Q4 2013, filed 14 Feb 2014.